又一次“头对头”胜出!康方生物双抗药物疗效“击败”百济神州PD-1

第一财经
23 Apr

4月23日,康方生物(09926.HK)港股盘中股价一度达到100港元/股,创出历史新高。早间,康方生物宣布,公司双抗药物依沃西单抗又一次在头对头试验中战胜了PD-1,这次挑战的对象是百济神州(ONC.NS、06160.HK、688235.SH)的替雷利珠单抗。4月23日,百济神州A股股价下跌1.42%。根据康方生物公布的消息,依沃西单抗(PD-1/VEGF双抗)联合化疗对比替雷利珠单抗联合化疗...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10